STOCK TITAN

Trulieve Cannabis Stock Price, News & Analysis

TCNNF OTC Link

Company Description

Trulieve Cannabis Corp. (OTCQX: TCNNF) is a vertically integrated cannabis company operating in the United States. The company is described in its public communications as an industry leading, top-performing multi-state operator with leading market positions in Arizona, Florida, and Pennsylvania. Trulieve is listed on the Canadian Securities Exchange (CSE) under the symbol TRUL and trades on the OTCQX market in the U.S. under the symbol TCNNF.

Trulieve operates within the broader cannabis manufacturing and retail ecosystem. The company highlights a vertically integrated structure, which means it is involved in multiple stages of the cannabis value chain, from cultivation and production through to branded retail distribution. Trulieve emphasizes building scale in retail and distribution in both new and existing markets through what it calls a hub strategy, aiming to expand its presence across multiple U.S. states.

Business model and operations

According to the company’s disclosures and news releases, Trulieve focuses on providing cannabis products to both medical patients and adult-use customers, depending on state regulations. The company states that it offers high-quality products across a portfolio of brands and that it aims to deliver what it describes as optimal customer experiences. Trulieve reports that a substantial majority of its revenue comes from retail sales and that it operates a large network of dispensaries and significant cultivation and processing capacity in the United States.

In its third quarter 2025 results, Trulieve reported revenue primarily from retail operations and referenced millions of branded products sold in a single quarter. The company also reported operating cash flow and free cash flow, indicating that it closely tracks profitability metrics such as gross margin and adjusted EBITDA. These disclosures suggest that Trulieve’s business model relies on scaling retail operations, managing production costs, and maintaining cash flow to support expansion and capital investments.

Geographic footprint and market positions

Trulieve describes itself as a multi-state operator with leading market positions in Arizona, Florida, and Pennsylvania. In addition to these core markets, the company has disclosed operations and branded retail presence in other states. For example, Trulieve and its partners operate Trulieve-branded dispensaries in Ohio, and the company has referenced distribution of certain branded THC beverages in Florida and Illinois. Trulieve has also announced that a subsidiary, Trulieve TX, Inc., received conditional approval for a Dispensing Organization license under the Texas Compassionate Use Program, which would allow it to cultivate, manufacture, and distribute medical cannabis products to patients in Texas, subject to final regulatory approval.

The company’s disclosures indicate that it operates hundreds of retail dispensaries and millions of square feet of cultivation and processing capacity in the United States. Trulieve’s communications emphasize a hub strategy, under which it builds scale in key regions and then extends retail and distribution into surrounding markets.

Products, brands, and customer focus

Trulieve’s public statements describe a portfolio of cannabis brands and product offerings. The company notes that its dispensaries offer a range of form factors, including capsules, concentrates, edibles, flower, pre-rolls, tinctures, topicals, and vaporizers. Within this portfolio, Trulieve highlights in-house brands such as Modern Flower and R.O., which are offered through its dispensary network. The company also references branded beverage lines, including Onward and Upward THC-infused beverages, which are described as Farm Bill-compliant and infused with naturally derived THC and CBD.

Trulieve reports that it serves both adult-use customers and medical patients, depending on state law. In Ohio, for example, a partner operates Trulieve-branded dispensaries that serve adult-use customers and medical patients, offering what is described as premium Trulieve products and a focus on customer experience. The company also notes that it has a substantial rewards or loyalty program membership base, with loyalty members accounting for a significant share of transactions in a reported quarter, which underscores its emphasis on repeat customers and brand engagement.

Capital structure and financing

Trulieve’s SEC filings and news releases describe the company’s use of debt financing through senior secured notes. In 2025, the company announced commitments for, and later the closing of, a private placement of 10.5% senior secured notes due 2030, with aggregate gross proceeds of approximately US$140 million. These notes were issued at 100% of face value under an existing indenture, with interest payable semi-annually and a maturity date in 2030. The notes are described as senior secured obligations of the company, ranking senior to its unsecured indebtedness and secured by a pledge of shares of a restricted subsidiary.

The company has also disclosed the redemption of previously issued 8.0% senior secured notes due 2026, with an aggregate principal amount of US$368 million. Trulieve reported that it used cash to redeem these notes and that the notes ceased trading and were delisted from the Canadian Securities Exchange. According to its filings, Trulieve intends to use net proceeds from its newer notes offerings for capital expenditures and general corporate purposes, aligning its capital structure with its expansion and operational objectives.

Regulatory environment and policy developments

As a cannabis company operating in the U.S., Trulieve is directly affected by federal and state regulatory frameworks. In a news release, the company publicly supported a decision by the Trump Administration to reclassify marijuana to Schedule III under the Controlled Substances Act. Trulieve characterized this potential rescheduling as an important step in cannabis reform, highlighting that it could ease barriers to medical marijuana research and remove the tax burden imposed by Section 280E of the U.S. tax code on state-legal cannabis operators. The company emphasized that rescheduling would not legalize marijuana but would acknowledge its medical benefits and allow for more robust research and more conventional tax treatment for licensed operators.

Trulieve’s communications also stress its support for licensed and regulated cannabis markets and its view that rescheduling aligns with efforts to distinguish state-legal operators from illicit market participants. The company notes that law enforcement agencies would retain authority to target illegal operators even under a Schedule III classification.

Operational metrics and scale

In its third quarter 2025 financial disclosures, Trulieve reported revenue, gross profit, and net loss figures, along with non-GAAP metrics such as adjusted EBITDA and free cash flow. The company disclosed that a large majority of its revenue in that quarter came from retail sales and that it sold over 12 million branded products in the quarter, indicating the scale of its consumer-facing operations. Trulieve also reported that it operated more than 200 retail dispensaries and several million square feet of cultivation and processing capacity across the United States at that time.

The company’s balance sheet data show significant investments in property and equipment, intangible assets, and goodwill, reflecting acquisitions and development of facilities. Trulieve also reports various categories of notes payable, lease liabilities, and construction finance liabilities, along with deferred tax liabilities and uncertain tax position liabilities, illustrating the complexity of operating in a heavily regulated sector with evolving tax treatment.

Technology, retail experience, and customer engagement

Trulieve has highlighted initiatives aimed at enhancing customer engagement and convenience. For example, the company reported launching a mobile app serving Florida customers, allowing patients to browse and reserve products, view promotions, and check rewards status through a digital interface. The company’s loyalty program has hundreds of thousands of members, and loyalty transactions represent a large share of total transactions, suggesting that Trulieve focuses on building long-term relationships with customers.

In addition to traditional dispensary operations, Trulieve and its partners have introduced branded beverage products, such as Onward cocktail alternatives and Upward infused energy drinks, with multiple flavors and THC/CBD formulations. These products are available online and at certain retail locations, and the company has noted strong demand for specific dosage formats. Such product launches illustrate Trulieve’s efforts to expand its brand presence into new categories within the cannabis and cannabinoid-based product space.

Corporate structure and jurisdiction

Trulieve Cannabis Corp. is incorporated in British Columbia, as indicated in its SEC filings, and files reports with the U.S. Securities and Exchange Commission. The company lists a principal executive office in Quincy, Florida, and provides a U.S. telephone number in its filings. Trulieve is subject to both Canadian and U.S. securities regulations, with its shares trading on the CSE and its U.S. listing on the OTCQX market.

Through its restricted subsidiaries, including Trulieve, Inc. (Trulieve US), the company guarantees certain debt obligations and maintains a structure that supports its U.S. operating footprint. The indentures governing its notes include covenants that limit activities such as incurring additional indebtedness, making certain investments, granting liens, entering into affiliate transactions, and conducting asset sales, reflecting typical protections for noteholders in a leveraged, growth-oriented business.

Position within the cannabis sector

Within the cannabis sector, Trulieve positions itself as a multi-state operator with significant retail and production scale. Its communications emphasize leading market positions in key states, a vertically integrated model, and a focus on branded products and customer experience. The company’s engagement with regulatory developments, such as federal rescheduling discussions and state-level licensing processes, underscores the importance of policy in shaping its operating environment.

Investors and observers looking at Trulieve often consider factors such as the company’s state-level market positions, its ability to manage regulatory and tax changes, its capital structure and debt obligations, and its track record of scaling retail and production operations. The company’s periodic financial reports, SEC filings, and news releases provide ongoing insight into these areas.

Stock Performance

$—
0.00%
0.00
Last updated:
55.93 %
Performance 1 year

Financial Highlights

$288,187
Revenue (TTM)
$213,605
Operating Cash Flow
$169,857
Gross Profit (TTM)

Upcoming Events

JAN
30
January 30, 2026 Operations

Fort Myers dispensary grand opening

17274 San Carlos Blvd, Fort Myers; walk-in/express pickup, home delivery; vets 20% off; 60% new-customer discount
APR
17
April 17, 2026 Financial

CSE listing after hold

Notes to be listed on the CSE after four-month Canadian hold following issuance
DEC
17
December 17, 2027 Financial

Redemption eligibility date

Notes may be redeemed in whole or part on/after this date; 10.5% senior secured notes
DEC
17
December 17, 2027 Financial

Redemption window opens

Issuer may redeem notes in whole or part starting two years after issuance
DEC
17
December 17, 2030 Financial

Notes maturity date

10.5% Senior Secured Notes due; principal payable at maturity; interest semi‑annual
DEC
17
December 17, 2030 Financial

Note maturity

10.5% Senior Secured Notes mature; principal payable on maturity date

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Trulieve Cannabis (TCNNF)?

The current stock price of Trulieve Cannabis (TCNNF) is $7.5 as of January 28, 2026.

What is the market cap of Trulieve Cannabis (TCNNF)?

The market cap of Trulieve Cannabis (TCNNF) is approximately 1.3B. Learn more about what market capitalization means .

What is the revenue (TTM) of Trulieve Cannabis (TCNNF) stock?

The trailing twelve months (TTM) revenue of Trulieve Cannabis (TCNNF) is $288,187.

What is the operating cash flow of Trulieve Cannabis (TCNNF)?

The operating cash flow of Trulieve Cannabis (TCNNF) is $213,605. Learn about cash flow.

What is the operating margin of Trulieve Cannabis (TCNNF)?

The operating profit margin of Trulieve Cannabis (TCNNF) is 0.15%. Learn about operating margins.

What is the gross margin of Trulieve Cannabis (TCNNF)?

The gross profit margin of Trulieve Cannabis (TCNNF) is 0.59%. Learn about gross margins.

What is the current ratio of Trulieve Cannabis (TCNNF)?

The current ratio of Trulieve Cannabis (TCNNF) is 6.09, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Trulieve Cannabis (TCNNF)?

The gross profit of Trulieve Cannabis (TCNNF) is $169,857 on a trailing twelve months (TTM) basis.

What is the operating income of Trulieve Cannabis (TCNNF)?

The operating income of Trulieve Cannabis (TCNNF) is $42,238. Learn about operating income.

What does Trulieve Cannabis Corp. do?

Trulieve Cannabis Corp. is a vertically integrated cannabis company and multi-state operator in the United States. The company is involved in cultivation, manufacturing, and retail distribution of cannabis products and reports that the majority of its revenue comes from retail sales through its dispensary network.

In which markets does Trulieve report leading positions?

Trulieve describes itself as having leading market positions in Arizona, Florida, and Pennsylvania. The company also reports operations and branded retail presence in other states, including Ohio, and distribution of certain products in Florida and Illinois.

On which exchanges does Trulieve Cannabis Corp. trade?

Trulieve Cannabis Corp. is listed on the Canadian Securities Exchange under the symbol TRUL and trades on the OTCQX market in the United States under the symbol TCNNF.

What types of cannabis products does Trulieve offer?

According to its public communications, Trulieve dispensaries offer a range of cannabis product forms, including capsules, concentrates, edibles, flower, pre-rolls, tinctures, topicals, and vaporizers. The company also highlights in-house brands such as Modern Flower and R.O., and THC-infused beverages under the Onward and Upward brands.

How large is Trulieve’s retail and production footprint?

In its third quarter 2025 disclosures, Trulieve reported operating more than 200 retail dispensaries and over four million square feet of cultivation and processing capacity in the United States. It also noted selling over 12 million branded products in a single quarter.

What is Trulieve’s approach to financing and debt?

Trulieve has used senior secured notes as a key financing tool. In 2025, the company announced commitments for, and the closing of, private placements of 10.5% senior secured notes due 2030, while also completing the redemption of US$368 million of 8.0% senior secured notes due 2026. The company stated that it intends to use net proceeds from the newer notes for capital expenditures and general corporate purposes.

How does federal cannabis policy affect Trulieve?

Trulieve has publicly commented on federal policy, including support for the Trump Administration’s decision to reclassify marijuana to Schedule III under the Controlled Substances Act. The company notes that such rescheduling would not legalize marijuana but could ease barriers to medical research and remove the Section 280E tax burden on state-legal cannabis operators.

What is Trulieve’s presence in Ohio?

Trulieve has disclosed that Harvest Grows LLC operates Trulieve-branded dispensaries in Ohio under a licensing agreement, while Trulieve itself operates owned dispensaries in several Ohio locations. These dispensaries serve adult-use customers and medical patients and offer Trulieve-branded products and various cannabis product forms.

What is the Texas Compassionate Use Program license mentioned by Trulieve?

Trulieve announced that Trulieve TX, Inc. received conditional approval for a Dispensing Organization license under the Texas Compassionate Use Program. Subject to final approval by the Texas Department of Public Safety, this license would allow the company to cultivate, manufacture, and distribute medical cannabis products to patients in Texas.

How does Trulieve engage with customers and loyalty programs?

Trulieve reports operating a rewards or loyalty program with hundreds of thousands of members, and it has noted that loyalty members account for a large share of transactions. The company has also launched a mobile app in Florida that allows patients to browse and reserve products, view promotions, and check rewards status.